JP2013507454A5 - - Google Patents

Download PDF

Info

Publication number
JP2013507454A5
JP2013507454A5 JP2012534338A JP2012534338A JP2013507454A5 JP 2013507454 A5 JP2013507454 A5 JP 2013507454A5 JP 2012534338 A JP2012534338 A JP 2012534338A JP 2012534338 A JP2012534338 A JP 2012534338A JP 2013507454 A5 JP2013507454 A5 JP 2013507454A5
Authority
JP
Japan
Prior art keywords
composition
dha
brain injury
risk
traumatic brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012534338A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013507454A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/052564 external-priority patent/WO2011047095A1/en
Publication of JP2013507454A publication Critical patent/JP2013507454A/ja
Publication of JP2013507454A5 publication Critical patent/JP2013507454A5/ja
Pending legal-status Critical Current

Links

JP2012534338A 2009-10-13 2010-10-13 外傷性脳損傷の病理学的影響の危険を軽減する方法 Pending JP2013507454A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25123009P 2009-10-13 2009-10-13
US61/251,230 2009-10-13
PCT/US2010/052564 WO2011047095A1 (en) 2009-10-13 2010-10-13 Reducing the risk of pathological effects of traumatic brain injury

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015217669A Division JP6516158B2 (ja) 2009-10-13 2015-11-05 外傷性脳損傷の病理学的影響の危険を軽減する方法

Publications (2)

Publication Number Publication Date
JP2013507454A JP2013507454A (ja) 2013-03-04
JP2013507454A5 true JP2013507454A5 (enExample) 2013-12-19

Family

ID=43876523

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012534338A Pending JP2013507454A (ja) 2009-10-13 2010-10-13 外傷性脳損傷の病理学的影響の危険を軽減する方法
JP2015217669A Expired - Fee Related JP6516158B2 (ja) 2009-10-13 2015-11-05 外傷性脳損傷の病理学的影響の危険を軽減する方法
JP2017174229A Expired - Fee Related JP6544747B2 (ja) 2009-10-13 2017-09-11 外傷性脳損傷の病理学的影響の危険を軽減する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015217669A Expired - Fee Related JP6516158B2 (ja) 2009-10-13 2015-11-05 外傷性脳損傷の病理学的影響の危険を軽減する方法
JP2017174229A Expired - Fee Related JP6544747B2 (ja) 2009-10-13 2017-09-11 外傷性脳損傷の病理学的影響の危険を軽減する方法

Country Status (8)

Country Link
US (2) US20110257267A1 (enExample)
EP (1) EP2488190B1 (enExample)
JP (3) JP2013507454A (enExample)
AU (1) AU2010306870B2 (enExample)
CA (1) CA2777367A1 (enExample)
ES (1) ES2643628T3 (enExample)
PL (1) PL2488190T3 (enExample)
WO (1) WO2011047095A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2777367A1 (en) 2009-10-13 2011-04-21 Martek Biosciences Corporation Reducing the risk of pathological effects of traumatic brain injury
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
US9269046B2 (en) * 2012-01-18 2016-02-23 Brainscope Company, Inc. Method and device for multimodal neurological evaluation
US8792974B2 (en) * 2012-01-18 2014-07-29 Brainscope Company, Inc. Method and device for multimodal neurological evaluation
CA3053187A1 (en) * 2017-02-09 2018-08-16 Bodhi Research & Development Inc. Cannabinoid-containing fatty acid formulations for treating disorders of the nervous system
EP3672585A4 (en) * 2017-08-25 2021-06-16 Struct Nutrition, LLC COMPOSITIONS AND PROCEDURES FOR THE PREVENTION, RELIEF, AND TREATMENT OF NEUROLOGICAL INJURY AFTER HEAD TRAUMA
KR101946362B1 (ko) 2017-10-27 2019-02-11 파이코일바이오텍코리아(주) 뇌 염증성 질환 예방, 개선 또는 치료용 조성물
EP3710591A4 (en) * 2017-11-17 2021-07-14 Guangxi Xiaozao Agricultural Technology Co., Ltd. PRODUCTION OF POLYUNSATURATED FATTY ACIDS EXTRACTED FROM SEAWEED
EP3874054A4 (en) 2018-11-02 2022-08-10 Mara Renewables Corporation ALGAE OIL WITH IMPROVED NUTRITIONAL VALUE
BR112021025477A2 (pt) 2019-06-20 2022-03-03 Aker Biomarine Antarctic As Formulações de lisofosfatidilcolina parenteral como lpc-dha, lpc-epa e seus usos em terapia
NL2023407B1 (en) 2019-06-28 2021-02-01 Aker Biomarine Antarctic As Parenteral lysophosphatidylcholine formulations
US20230398088A1 (en) * 2020-10-30 2023-12-14 The Trustees Of The University Of Pennsylvania Lipid Prophylactic Brain Injury Treatment
FR3132430B1 (fr) * 2022-02-09 2025-04-25 Polaris Composition comprenant un melange de dha et/ou d’epa et d’un phospholipide d’orgine vegetale

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US6681403B2 (en) * 2000-03-13 2004-01-27 Robert M. Lyden Shin-guard, helmet, and articles of protective equipment including light cure material
US6469049B1 (en) * 2000-04-21 2002-10-22 The United States Of America As Represented By The Secretary Of The Army Method of treating, preventing or inhibiting central nervous system injuries and diseases
WO2003043570A2 (en) * 2001-11-15 2003-05-30 Galileo Laboratories, Inc. Formulations and methods for treatment or amelioration of inflammatory conditions
BRPI0418092A (pt) * 2003-12-23 2007-04-17 Pfizer Prod Inc combinação terapêutica para melhora cognitiva e transtornos psicóticos
US20050164908A1 (en) 2004-01-23 2005-07-28 Ginsberg Myron D. Neuroprotective complex for treatment of cerebral ischemia and injury
US20060276373A1 (en) * 2004-01-23 2006-12-07 Bazan Nicolas G Neuroprotective complex for treatment of cerebral ischemia and injury
US20060059605A1 (en) * 2004-09-22 2006-03-23 Xenith Athletics, Inc. Layered construction of protective headgear with one or more compressible layers of thermoplastic elastomer material
JP5697293B2 (ja) * 2005-06-30 2015-04-08 サントリーホールディングス株式会社 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物
CN101262863B (zh) * 2005-07-08 2016-08-31 Dsmip资产公司 用于治疗痴呆和前痴呆相关病症的多不饱和脂肪酸
US20080038237A1 (en) * 2006-02-28 2008-02-14 Sapolsky Robert M Trojan horse immunotherapy
CN101049297B (zh) * 2006-04-06 2010-11-24 北京百慧生化制药有限责任公司 一种高dha型-乙酯和epa-乙酯的脂肪酸乙酯及其制造方法和制剂
MX374545B (es) * 2007-06-29 2025-03-06 Dsm Ip Assets Bv Produccion y purificacion de esteres de acidos grasos poliinsaturados.
WO2009057994A1 (en) 2007-11-02 2009-05-07 N.V. Nutricia Unit dosage for brain health
CA2777367A1 (en) 2009-10-13 2011-04-21 Martek Biosciences Corporation Reducing the risk of pathological effects of traumatic brain injury
CN109350408B (zh) * 2018-12-11 2024-06-14 陶国民 过床护理椅

Similar Documents

Publication Publication Date Title
JP2013507454A5 (enExample)
JP2016053065A5 (enExample)
HRP20210686T1 (hr) Pripravci i postupci za liječenje moždanog udara kod subjekta na istodobnoj terapiji statinom
CN104981253B (zh) 固溶体组合物及其在慢性炎症中的用途
JP5441287B2 (ja) 心血管事象を予防するための必須脂肪酸
EP1982710B1 (en) Composition for prevention of recurrence of stroke
US20110105510A1 (en) Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis
JP5575655B2 (ja) 腎保護剤としての中鎖長脂肪酸およびグリセリド
ES2585066T3 (es) Composiciones para el tratamiento de trastornos neurológicos
CN105120872B (zh) 包含15-hepe的组合物以及其使用方法
JP2008540394A5 (enExample)
JP2015503590A5 (enExample)
RU2017112149A (ru) Комбинация омега-3 жирной кислоты и SGLT-2 ингибитора для лечения болезней печени
RU2016129266A (ru) Композиции и способы лечения и/или предотвращения сердечно-сосудистого заболевания
JP2015143248A5 (enExample)
ES2900593T3 (es) Composiciones que comprenden 15-HEPE y su uso para tratar o prevenir la fibrosis pulmonar idiopática
WO2011118976A3 (en) Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
RU2010120706A (ru) Композиция липоевой кислоты в виде шариков
JP2007518764A (ja) 中枢神経系障害の治療のための、選択されたｎ−３系脂肪酸の高度濃縮組成物の使用
CN1280498A (zh) 葡萄提取物的膦脂复合物作为抗动脉粥样硬化剂的应用
EP3461479B1 (en) Nutraceutical and pharmaceutical compositions, and uses thereof for preserving cognitive functions
JP2020526485A5 (enExample)
KR20050010464A (ko) 치료제
AU2018321407A1 (en) Compositions and methods for preventing, alleviating, and treating neurological injury following head trauma
TW201827047A (zh) 用於預防及/或治療惡病質的ω-3脂肪酸組合物